¿Ã·¹Æ÷Æ® : ´ëÇз¹Æ÷Æ®, Á·º¸, ½ÇÇè°úÁ¦, ½Ç½ÀÀÏÁö, ±â¾÷ºÐ¼®, »ç¾÷°èȹ¼­, Çо÷°èȹ¼­, ÀÚ±â¼Ò°³¼­, ¸éÁ¢, ¹æ¼ÛÅë½Å´ëÇÐ, ½ÃÇè ÀÚ·á½Ç
¿Ã·¹Æ÷Æ® : ´ëÇз¹Æ÷Æ®, Á·º¸, ½ÇÇè°úÁ¦, ½Ç½ÀÀÏÁö, ±â¾÷ºÐ¼®, »ç¾÷°èȹ¼­, Çо÷°èȹ¼­, ÀÚ±â¼Ò°³¼­, ¸éÁ¢, ¹æ¼ÛÅë½Å´ëÇÐ, ½ÃÇè ÀÚ·á½Ç
·Î±×ÀΠ ȸ¿ø°¡ÀÔ

ÆÄÆ®³Ê½º

ÀÚ·áµî·Ï
 

Àå¹Ù±¸´Ï

´Ù½Ã¹Þ±â

ÄÚÀÎÃæÀü

¢¸
  • Changing Needs in Drug Delivery in the Era of Peptide and Protein Drugs   (1 ÆäÀÌÁö)
    1

  • Changing Needs in Drug Delivery in the Era of Peptide and Protein Drugs   (2 ÆäÀÌÁö)
    2

  • Changing Needs in Drug Delivery in the Era of Peptide and Protein Drugs   (3 ÆäÀÌÁö)
    3

  • Changing Needs in Drug Delivery in the Era of Peptide and Protein Drugs   (4 ÆäÀÌÁö)
    4

  • Changing Needs in Drug Delivery in the Era of Peptide and Protein Drugs   (5 ÆäÀÌÁö)
    5

  • Changing Needs in Drug Delivery in the Era of Peptide and Protein Drugs   (6 ÆäÀÌÁö)
    6

  • Changing Needs in Drug Delivery in the Era of Peptide and Protein Drugs   (7 ÆäÀÌÁö)
    7

  • Changing Needs in Drug Delivery in the Era of Peptide and Protein Drugs   (8 ÆäÀÌÁö)
    8

  • Changing Needs in Drug Delivery in the Era of Peptide and Protein Drugs   (9 ÆäÀÌÁö)
    9

  • Changing Needs in Drug Delivery in the Era of Peptide and Protein Drugs   (10 ÆäÀÌÁö)
    10

  • Changing Needs in Drug Delivery in the Era of Peptide and Protein Drugs   (11 ÆäÀÌÁö)
    11

  • Changing Needs in Drug Delivery in the Era of Peptide and Protein Drugs   (12 ÆäÀÌÁö)
    12

  • Changing Needs in Drug Delivery in the Era of Peptide and Protein Drugs   (13 ÆäÀÌÁö)
    13

  • Changing Needs in Drug Delivery in the Era of Peptide and Protein Drugs   (14 ÆäÀÌÁö)
    14

  • Changing Needs in Drug Delivery in the Era of Peptide and Protein Drugs   (15 ÆäÀÌÁö)
    15


  • º» ¹®¼­ÀÇ
    ¹Ì¸®º¸±â´Â
    15 Pg ±îÁö¸¸
    °¡´ÉÇÕ´Ï´Ù.
¢º
Ŭ¸¯ : Å©°Ôº¸±â
  • Changing Needs in Drug Delivery in the Era of Peptide and Protein Drugs   (1 ÆäÀÌÁö)
    1

  • Changing Needs in Drug Delivery in the Era of Peptide and Protein Drugs   (2 ÆäÀÌÁö)
    2

  • Changing Needs in Drug Delivery in the Era of Peptide and Protein Drugs   (3 ÆäÀÌÁö)
    3

  • Changing Needs in Drug Delivery in the Era of Peptide and Protein Drugs   (4 ÆäÀÌÁö)
    4

  • Changing Needs in Drug Delivery in the Era of Peptide and Protein Drugs   (5 ÆäÀÌÁö)
    5

  • Changing Needs in Drug Delivery in the Era of Peptide and Protein Drugs   (6 ÆäÀÌÁö)
    6

  • Changing Needs in Drug Delivery in the Era of Peptide and Protein Drugs   (7 ÆäÀÌÁö)
    7

  • Changing Needs in Drug Delivery in the Era of Peptide and Protein Drugs   (8 ÆäÀÌÁö)
    8

  • Changing Needs in Drug Delivery in the Era of Peptide and Protein Drugs   (9 ÆäÀÌÁö)
    9

  • Changing Needs in Drug Delivery in the Era of Peptide and Protein Drugs   (10 ÆäÀÌÁö)
    10



  • º» ¹®¼­ÀÇ
    (Å« À̹ÌÁö)
    ¹Ì¸®º¸±â´Â
    10 Page ±îÁö¸¸
    °¡´ÉÇÕ´Ï´Ù.
  ´õºíŬ¸¯ : ´Ý±â
X ´Ý±â
Á¿ìÀ̵¿ : µå·¡±×

Changing Needs in Drug Delivery in the Era of Peptide and Protein Drugs

ÀÎ ¼â
¹Ù·Î°¡±â
Áñ°Üã±â Űº¸µå¸¦ ´­·¯ÁÖ¼¼¿ä
( Ctrl + D )
¸µÅ©º¹»ç ¸µÅ©ÁÖ¼Ò°¡ º¹»ç µÇ¾ú½À´Ï´Ù.
¿øÇÏ´Â °÷¿¡ ºÙÇô³Ö±â Çϼ¼¿ä
( Ctrl + V )
¿ÜºÎ°øÀ¯
ÆÄÀÏ  Changing Needs in Drug Delivery in the Era of Pept~.hwp   [Size : 766 Kbyte ]
ºÐ·®   133 Page
°¡°Ý  3,000 ¿ø


īƮ
´Ù¿î¹Þ±â
īī¿À ID·Î
´Ù¿î ¹Þ±â
±¸±Û ID·Î
´Ù¿î ¹Þ±â
ÆäÀ̽ººÏ ID·Î
´Ù¿î ¹Þ±â
µÚ·Î

ÀÚ·á¼³¸í
B. Processing and Formulation Condition

1) ¿Âµµ
- ´ëºÎºÐÀÇ ´Ü¹éÁúÀº ¿Âµµ Áõ°¡¿Í ´õºÒ¾î °¡¿ª...
º»¹®/³»¿ë
B. Processing and Formulation Condition

1) ¿Âµµ

- ´ëºÎºÐÀÇ ´Ü¹éÁúÀº ¿Âµµ Áõ°¡¿Í ´õºÒ¾î °¡¿ªÀûÀ¸·Î denaturation
- ¿ÂµµÀÇ °è¼ÓÀû Áõ°¡·Î denaturationÃËÁøµÇ°í coolingÀ¸·Îµµ reverseµÇÁö ¾ÊÀ½
- ¾î¶² °æ¿ì¿¡ original native structure ¿Í ´Ù¸¥ »õ·Î¿î ±¸Á¶·Î unfoldµÇ°í refoldµÊ
- ¿Âµµ¸¦ ³·Ãá °æ¿ì¿¡µµ native structure·ÎÀÇ refolding ¹æÇØÇÏ´Â ³ôÀº kinetic energy barrier
¶§¹®¿¡ proteinÀº ÀÌ·± misfoldedµÈ »óÅ·ΠÁ¸Àç
- ³·Àº ¿Âµµ¿¡ÀÇ ³ëÃâÀº cold denaturation : reverse enthalpic & entropic effect·Î ÀϾ

2) pH

- formulation bufferÀÇ pH´Â È­ÇÐÀûÀ¸·Î amino aò Àܱ⠹ٲٴ protein solubility, folding,
¹ÝÀÀ¼Óµµ¿¡ ½É°¢ÇÑ Ãæ°ÝÀ» ÁÙ ¼ö ÀÖ´Ù.

3) Ionic Strength À̿°­µµ

- counterionÀÇ ³óµµ´Â ºÐÀÚ¿¡¼­ Á¤Àü±âÀûÀηÂÀ» ¸Å°³ÇÏ´Â Áß¿äÇÑ Æ¯¼ºÀ̰í proteinÀÇ
solubility»Ó¸¸ ¾Æ´Ï¶ó stability¿¡ Å« È¿°ú¸¦ °¡Áø´Ù.
- ÀüÇØÁúÀÇ Debye-Huckel theory : Á¤Àü±âÀû Àη¿¡ counterion³óµµÀÇ È¿°ú
(Ci: charge ZiÀÇ counte¡¦(»ý·«)

4) ´Ù¸¥ formulation componentÀÇ È¿°ú




📝 Regist Info
I D : hyny****
Date : 2015-09-19
FileNo : 16064884

Cart